

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.07020354 |
| 2 | viral transcription (GO:0019083) | 6.77955116 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 6.61491560 |
| 4 | translational termination (GO:0006415) | 6.40976104 |
| 5 | daunorubicin metabolic process (GO:0044597) | 6.14825907 |
| 6 | polyketide metabolic process (GO:0030638) | 6.14825907 |
| 7 | doxorubicin metabolic process (GO:0044598) | 6.14825907 |
| 8 | piRNA metabolic process (GO:0034587) | 5.97384231 |
| 9 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.86715169 |
| 10 | translational elongation (GO:0006414) | 5.50562242 |
| 11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.48076947 |
| 12 | thyroid gland development (GO:0030878) | 5.37858996 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 5.35007217 |
| 14 | protein targeting to ER (GO:0045047) | 5.33293121 |
| 15 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 5.32271138 |
| 16 | purine nucleotide salvage (GO:0032261) | 5.28298268 |
| 17 | viral life cycle (GO:0019058) | 5.10909407 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 5.10847016 |
| 19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.09133804 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.07490217 |
| 21 | ADP metabolic process (GO:0046031) | 5.04105030 |
| 22 | protein localization to endoplasmic reticulum (GO:0070972) | 5.00281828 |
| 23 | cellular protein complex disassembly (GO:0043624) | 4.87161121 |
| 24 | AMP metabolic process (GO:0046033) | 4.80988388 |
| 25 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.80601654 |
| 26 | regulation of female gonad development (GO:2000194) | 4.76036301 |
| 27 | mature B cell differentiation involved in immune response (GO:0002313) | 4.60233079 |
| 28 | translational initiation (GO:0006413) | 4.47229652 |
| 29 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.46985710 |
| 30 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.46934827 |
| 31 | negative regulation of B cell apoptotic process (GO:0002903) | 4.42126107 |
| 32 | protein complex disassembly (GO:0043241) | 4.34289543 |
| 33 | definitive hemopoiesis (GO:0060216) | 4.31084084 |
| 34 | positive regulation of catecholamine secretion (GO:0033605) | 4.16420752 |
| 35 | DNA methylation involved in gamete generation (GO:0043046) | 4.13530696 |
| 36 | ribosomal large subunit biogenesis (GO:0042273) | 4.05032460 |
| 37 | macromolecular complex disassembly (GO:0032984) | 4.04183773 |
| 38 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.01551538 |
| 39 | Peyers patch development (GO:0048541) | 4.01551538 |
| 40 | DNA deamination (GO:0045006) | 3.99901477 |
| 41 | regulation of skeletal muscle contraction (GO:0014819) | 3.96392772 |
| 42 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.84231761 |
| 43 | endothelium development (GO:0003158) | 3.82855966 |
| 44 | nucleotide salvage (GO:0043173) | 3.77371979 |
| 45 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.72529286 |
| 46 | cranial nerve morphogenesis (GO:0021602) | 3.71920763 |
| 47 | aggressive behavior (GO:0002118) | 3.71577215 |
| 48 | * negative regulation of epidermis development (GO:0045683) | 3.71548776 |
| 49 | purine-containing compound salvage (GO:0043101) | 3.69768138 |
| 50 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.69621729 |
| 51 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.68247911 |
| 52 | rRNA transcription (GO:0009303) | 3.64406006 |
| 53 | regulation of response to osmotic stress (GO:0047484) | 3.63641073 |
| 54 | protein targeting to membrane (GO:0006612) | 3.60474031 |
| 55 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.59690921 |
| 56 | protein localization to kinetochore (GO:0034501) | 3.57162258 |
| 57 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.56243912 |
| 58 | mRNA catabolic process (GO:0006402) | 3.55204129 |
| 59 | multicellular organism reproduction (GO:0032504) | 3.50630489 |
| 60 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.49573371 |
| 61 | lymphoid progenitor cell differentiation (GO:0002320) | 3.43759824 |
| 62 | DNA replication checkpoint (GO:0000076) | 3.42401355 |
| 63 | muscle organ morphogenesis (GO:0048644) | 3.40755332 |
| 64 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.40699788 |
| 65 | platelet dense granule organization (GO:0060155) | 3.34085766 |
| 66 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.32758363 |
| 67 | regulation of memory T cell differentiation (GO:0043380) | 3.30827045 |
| 68 | RNA catabolic process (GO:0006401) | 3.30646876 |
| 69 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.27228694 |
| 70 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.25265162 |
| 71 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.22846474 |
| 72 | muscle filament sliding (GO:0030049) | 3.22145101 |
| 73 | actin-myosin filament sliding (GO:0033275) | 3.22145101 |
| 74 | pseudouridine synthesis (GO:0001522) | 3.20409634 |
| 75 | regulation of steroid hormone secretion (GO:2000831) | 3.18793879 |
| 76 | positive regulation of odontogenesis (GO:0042482) | 3.17895229 |
| 77 | UV protection (GO:0009650) | 3.17668065 |
| 78 | negative regulation of interleukin-2 production (GO:0032703) | 3.16759058 |
| 79 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.15110403 |
| 80 | mature B cell differentiation (GO:0002335) | 3.15019951 |
| 81 | positive regulation of steroid hormone secretion (GO:2000833) | 3.13991670 |
| 82 | megakaryocyte development (GO:0035855) | 3.13743586 |
| 83 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.13453205 |
| 84 | mesonephros development (GO:0001823) | 3.13297693 |
| 85 | translation (GO:0006412) | 3.13131237 |
| 86 | DNA unwinding involved in DNA replication (GO:0006268) | 3.12236422 |
| 87 | regulation of female receptivity (GO:0045924) | 3.11397567 |
| 88 | male meiosis I (GO:0007141) | 3.10771174 |
| 89 | synapsis (GO:0007129) | 3.07694217 |
| 90 | negative regulation of phagocytosis (GO:0050765) | 3.06505505 |
| 91 | negative regulation of circadian rhythm (GO:0042754) | 3.06371059 |
| 92 | reproduction (GO:0000003) | 3.04994846 |
| 93 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.04487246 |
| 94 | deoxyribonucleotide catabolic process (GO:0009264) | 3.02427169 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01127699 |
| 96 | female mating behavior (GO:0060180) | 3.00703737 |
| 97 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.99535995 |
| 98 | grooming behavior (GO:0007625) | 2.98253393 |
| 99 | cellular ketone body metabolic process (GO:0046950) | 2.97802827 |
| 100 | deoxyribose phosphate catabolic process (GO:0046386) | 2.96800534 |
| 101 | deoxyribose phosphate metabolic process (GO:0019692) | 2.95467718 |
| 102 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.94905176 |
| 103 | lymph vessel development (GO:0001945) | 2.93655189 |
| 104 | negative regulation of kidney development (GO:0090185) | 2.90737603 |
| 105 | muscle cell fate commitment (GO:0042693) | 2.86900734 |
| 106 | protein localization to chromosome, centromeric region (GO:0071459) | 2.86730050 |
| 107 | fertilization (GO:0009566) | 2.85945509 |
| 108 | base-excision repair, AP site formation (GO:0006285) | 2.85334233 |
| 109 | single fertilization (GO:0007338) | 2.84185466 |
| 110 | skeletal muscle contraction (GO:0003009) | 2.82328711 |
| 111 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.81781044 |
| 112 | formation of translation preinitiation complex (GO:0001731) | 2.80801123 |
| 113 | cellular component biogenesis (GO:0044085) | 2.79117967 |
| 114 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.78852495 |
| 115 | deoxyribonucleotide metabolic process (GO:0009262) | 2.77161223 |
| 116 | protein kinase C signaling (GO:0070528) | 2.76216091 |
| 117 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.76113217 |
| 118 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.76113217 |
| 119 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.75865473 |
| 120 | regulation of penile erection (GO:0060405) | 2.75585672 |
| 121 | regulation of necrotic cell death (GO:0010939) | 2.74020368 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72694442 |
| 123 | desmosome organization (GO:0002934) | 2.72531652 |
| 124 | positive regulation of interleukin-17 production (GO:0032740) | 2.71539470 |
| 125 | male meiosis (GO:0007140) | 2.69061771 |
| 126 | meiosis I (GO:0007127) | 2.67763047 |
| 127 | DNA damage response, detection of DNA damage (GO:0042769) | 2.66910418 |
| 128 | maintenance of protein location in nucleus (GO:0051457) | 2.66393064 |
| 129 | sphingoid metabolic process (GO:0046519) | 2.65716238 |
| 130 | actin-mediated cell contraction (GO:0070252) | 2.64170805 |
| 131 | positive regulation of digestive system process (GO:0060456) | 2.64026089 |
| 132 | meiotic cell cycle (GO:0051321) | 2.63625610 |
| 133 | valine metabolic process (GO:0006573) | 2.62343101 |
| 134 | rRNA processing (GO:0006364) | 2.60795890 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.60216763 |
| 136 | negative regulation of telomere maintenance (GO:0032205) | 2.59832331 |
| 137 | * negative regulation of epidermal cell differentiation (GO:0045605) | 2.59378377 |
| 138 | positive regulation of activated T cell proliferation (GO:0042104) | 2.58312121 |
| 139 | fucose catabolic process (GO:0019317) | 2.58192611 |
| 140 | L-fucose metabolic process (GO:0042354) | 2.58192611 |
| 141 | L-fucose catabolic process (GO:0042355) | 2.58192611 |
| 142 | positive regulation of protein deacetylation (GO:0090312) | 2.57910791 |
| 143 | meiotic nuclear division (GO:0007126) | 2.57747379 |
| 144 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.57606883 |
| 145 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.57077144 |
| 146 | ribosome biogenesis (GO:0042254) | 2.55801367 |
| 147 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.54343131 |
| 148 | positive regulation of defense response to virus by host (GO:0002230) | 2.54300687 |
| 149 | ketone body metabolic process (GO:1902224) | 2.53814432 |
| 150 | rRNA metabolic process (GO:0016072) | 2.53547036 |
| 151 | establishment of protein localization to membrane (GO:0090150) | 2.52562520 |
| 152 | DNA replication initiation (GO:0006270) | 2.52554739 |
| 153 | phospholipid scrambling (GO:0017121) | 2.52451922 |
| 154 | pattern specification involved in kidney development (GO:0061004) | 2.52006691 |
| 155 | autophagic vacuole fusion (GO:0000046) | 2.51799183 |
| 156 | short-chain fatty acid metabolic process (GO:0046459) | 2.51560866 |
| 157 | interferon-gamma production (GO:0032609) | 2.50687483 |
| 158 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.49581111 |
| 159 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49390185 |
| 160 | regulation of necroptotic process (GO:0060544) | 2.47768837 |
| 161 | negative regulation of telomerase activity (GO:0051974) | 2.47628122 |
| 162 | histone H4-K12 acetylation (GO:0043983) | 2.47618843 |
| 163 | cellular metabolic compound salvage (GO:0043094) | 2.47488862 |
| 164 | purine nucleobase metabolic process (GO:0006144) | 2.47180018 |
| 165 | skeletal muscle tissue regeneration (GO:0043403) | 2.47109307 |
| 166 | response to muscle activity (GO:0014850) | 2.46926344 |
| 167 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.46337375 |
| 168 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.46258479 |
| 169 | maternal behavior (GO:0042711) | 2.43517247 |
| 170 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43274931 |
| 171 | synaptonemal complex assembly (GO:0007130) | 2.42538176 |
| 172 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.42150631 |
| 173 | vesicle fusion (GO:0006906) | 2.40949293 |
| 174 | female gamete generation (GO:0007292) | 2.40611074 |
| 175 | negative regulation of necroptotic process (GO:0060546) | 2.39419324 |
| 176 | chromosome organization involved in meiosis (GO:0070192) | 2.39294304 |
| 177 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.38972003 |
| 178 | gene silencing by RNA (GO:0031047) | 2.37719820 |
| 179 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.37637560 |
| 180 | hematopoietic stem cell proliferation (GO:0071425) | 2.37551439 |
| 181 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.37384832 |
| 182 | regulation of respiratory burst (GO:0060263) | 2.36394197 |
| 183 | hemidesmosome assembly (GO:0031581) | 2.35961268 |
| 184 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.34804847 |
| 185 | mitochondrial DNA replication (GO:0006264) | 2.34763518 |
| 186 | mitotic chromosome condensation (GO:0007076) | 2.33726667 |
| 187 | cytidine metabolic process (GO:0046087) | 2.32745790 |
| 188 | cytidine catabolic process (GO:0006216) | 2.32745790 |
| 189 | cytidine deamination (GO:0009972) | 2.32745790 |
| 190 | cellular hyperosmotic response (GO:0071474) | 2.32414058 |
| 191 | rRNA methylation (GO:0031167) | 2.31293087 |
| 192 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.30512673 |
| 193 | positive regulation of B cell differentiation (GO:0045579) | 2.29026845 |
| 194 | regulation of hair follicle development (GO:0051797) | 2.29008600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.53073073 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.32643206 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03236723 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.51773090 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.32228827 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.20801138 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.96083341 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.96083341 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.96083341 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.92101060 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.88093297 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.81968012 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.59728938 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.58632502 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.47968980 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38220013 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38187961 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30178252 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.26725165 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26222948 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25428159 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.20397887 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.05892847 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.05861145 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02208727 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02035163 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93198824 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.90325118 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90018938 |
| 30 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.89959250 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88411046 |
| 32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84497410 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80670704 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79466393 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.78853990 |
| 36 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.78675831 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78479881 |
| 38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77702724 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.75606018 |
| 40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.73801252 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72116747 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70412495 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68263831 |
| 44 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.67412830 |
| 45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.66311145 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65439871 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62045427 |
| 48 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.59957126 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59036152 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58130209 |
| 51 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54260423 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53389198 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48666731 |
| 54 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.47517680 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45531596 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45510448 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.45248301 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.44807654 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44329406 |
| 60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.43876392 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.42528904 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41035238 |
| 63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39818028 |
| 64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38118586 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36458598 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34420271 |
| 67 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32354443 |
| 68 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32147307 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31122468 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27491703 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27266385 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25399056 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24156640 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23795773 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23299424 |
| 76 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.22888061 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22395333 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22020168 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21770433 |
| 80 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20983000 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18759589 |
| 82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18708873 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18631100 |
| 84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18358208 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.17781595 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16694385 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15451489 |
| 88 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14070622 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13736947 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13731872 |
| 91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13264038 |
| 92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12222840 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 1.11834914 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10765354 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10524554 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10385340 |
| 97 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08784087 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08641751 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07718863 |
| 100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07428014 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07110671 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06394830 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05322849 |
| 104 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.04461619 |
| 105 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02222541 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02192815 |
| 107 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.01441060 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00344849 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00179202 |
| 110 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.98992969 |
| 111 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98941006 |
| 112 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.98938860 |
| 113 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98367168 |
| 114 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97791127 |
| 115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97548664 |
| 116 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97111148 |
| 117 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97004388 |
| 118 | MAF_26560356_Chip-Seq_TH1_Human | 0.95945294 |
| 119 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.94910065 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94754477 |
| 121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94682049 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94484869 |
| 123 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94079321 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92903800 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92761277 |
| 126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91752430 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90818192 |
| 128 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89967738 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89896372 |
| 130 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89724325 |
| 131 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.88963551 |
| 132 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.88679877 |
| 133 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88308863 |
| 134 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88175221 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87619867 |
| 136 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87382776 |
| 137 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87062704 |
| 138 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86555941 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85654070 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85278156 |
| 141 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84230098 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83817208 |
| 143 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82929783 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82848339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.81503907 |
| 2 | MP0003718_maternal_effect | 3.48592251 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.41774610 |
| 4 | MP0004381_abnormal_hair_follicle | 3.04308684 |
| 5 | MP0005075_abnormal_melanosome_morpholog | 2.88070003 |
| 6 | MP0002160_abnormal_reproductive_system | 2.81975827 |
| 7 | MP0002234_abnormal_pharynx_morphology | 2.80340867 |
| 8 | MP0003011_delayed_dark_adaptation | 2.79222282 |
| 9 | MP0000681_abnormal_thyroid_gland | 2.54816470 |
| 10 | MP0002796_impaired_skin_barrier | 2.48816491 |
| 11 | MP0001188_hyperpigmentation | 2.47596854 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.27482040 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.24710731 |
| 14 | MP0000383_abnormal_hair_follicle | 2.24202778 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.20778811 |
| 16 | MP0004782_abnormal_surfactant_physiolog | 2.20019762 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.16231739 |
| 18 | MP0003315_abnormal_perineum_morphology | 2.15593304 |
| 19 | MP0002254_reproductive_system_inflammat | 2.11774140 |
| 20 | MP0002132_abnormal_respiratory_system | 2.09788274 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.09115289 |
| 22 | MP0000490_abnormal_crypts_of | 2.08743330 |
| 23 | MP0002249_abnormal_larynx_morphology | 2.07709601 |
| 24 | MP0002108_abnormal_muscle_morphology | 2.04327680 |
| 25 | MP0000749_muscle_degeneration | 2.03160223 |
| 26 | MP0001664_abnormal_digestion | 1.98396326 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.95044380 |
| 28 | MP0005501_abnormal_skin_physiology | 1.90945891 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.88587021 |
| 30 | MP0010030_abnormal_orbit_morphology | 1.85526065 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.83011782 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.79512902 |
| 33 | MP0005503_abnormal_tendon_morphology | 1.78079804 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.76464592 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.75678419 |
| 36 | MP0003941_abnormal_skin_development | 1.75238080 |
| 37 | MP0009697_abnormal_copulation | 1.72248357 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.72151828 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.70313568 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.70313568 |
| 41 | MP0003938_abnormal_ear_development | 1.70225407 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.69460375 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.67193667 |
| 44 | MP0000762_abnormal_tongue_morphology | 1.66266866 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.66130928 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.65807607 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.65099718 |
| 48 | MP0003646_muscle_fatigue | 1.64689879 |
| 49 | MP0001764_abnormal_homeostasis | 1.61303300 |
| 50 | MP0004233_abnormal_muscle_weight | 1.56965154 |
| 51 | MP0005389_reproductive_system_phenotype | 1.56936182 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.55930586 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.54657008 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.49205686 |
| 55 | MP0005360_urolithiasis | 1.49076558 |
| 56 | MP0003077_abnormal_cell_cycle | 1.47004901 |
| 57 | MP0000751_myopathy | 1.46336360 |
| 58 | MP0002060_abnormal_skin_morphology | 1.46155892 |
| 59 | MP0005395_other_phenotype | 1.46082557 |
| 60 | MP0001661_extended_life_span | 1.45321251 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.44919761 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.42117952 |
| 63 | MP0008057_abnormal_DNA_replication | 1.37820057 |
| 64 | MP0000733_abnormal_muscle_development | 1.37274142 |
| 65 | MP0000377_abnormal_hair_follicle | 1.36712480 |
| 66 | MP0002932_abnormal_joint_morphology | 1.35698931 |
| 67 | MP0002009_preneoplasia | 1.35065785 |
| 68 | MP0000049_abnormal_middle_ear | 1.33458134 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.32928859 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.28754601 |
| 71 | MP0005275_abnormal_skin_tensile | 1.28365443 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.25070047 |
| 73 | MP0008932_abnormal_embryonic_tissue | 1.24666366 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.24417996 |
| 75 | MP0005330_cardiomyopathy | 1.23507096 |
| 76 | MP0010678_abnormal_skin_adnexa | 1.23027638 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.22848356 |
| 78 | MP0005410_abnormal_fertilization | 1.22305666 |
| 79 | MP0003045_fibrosis | 1.21793215 |
| 80 | MP0001849_ear_inflammation | 1.20101699 |
| 81 | MP0005369_muscle_phenotype | 1.19975694 |
| 82 | MP0010771_integument_phenotype | 1.19659512 |
| 83 | MP0001270_distended_abdomen | 1.16415928 |
| 84 | MP0000747_muscle_weakness | 1.16063755 |
| 85 | MP0003111_abnormal_nucleus_morphology | 1.10506127 |
| 86 | MP0003942_abnormal_urinary_system | 1.09826004 |
| 87 | MP0002095_abnormal_skin_pigmentation | 1.09263447 |
| 88 | MP0001929_abnormal_gametogenesis | 1.08400839 |
| 89 | MP0002127_abnormal_cardiovascular_syste | 1.04719889 |
| 90 | MP0004087_abnormal_muscle_fiber | 1.04288233 |
| 91 | MP0005023_abnormal_wound_healing | 1.03959270 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.02996193 |
| 93 | MP0008058_abnormal_DNA_repair | 1.02041730 |
| 94 | MP0001881_abnormal_mammary_gland | 1.01878611 |
| 95 | MP0005499_abnormal_olfactory_system | 1.01740763 |
| 96 | MP0005394_taste/olfaction_phenotype | 1.01740763 |
| 97 | * MP0002114_abnormal_axial_skeleton | 1.00928563 |
| 98 | MP0004858_abnormal_nervous_system | 1.00863572 |
| 99 | MP0002019_abnormal_tumor_incidence | 1.00664559 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 1.00483314 |
| 101 | MP0005508_abnormal_skeleton_morphology | 0.99395776 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 0.98709316 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.98653908 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.96161617 |
| 105 | MP0002233_abnormal_nose_morphology | 0.96029050 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.95963485 |
| 107 | MP0003136_yellow_coat_color | 0.95343964 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.95065537 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.94672468 |
| 110 | MP0004043_abnormal_pH_regulation | 0.94297118 |
| 111 | MP0002006_tumorigenesis | 0.92602584 |
| 112 | MP0002398_abnormal_bone_marrow | 0.92480885 |
| 113 | MP0002269_muscular_atrophy | 0.92302223 |
| 114 | * MP0002722_abnormal_immune_system | 0.91536971 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.91529823 |
| 116 | MP0002109_abnormal_limb_morphology | 0.91512192 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.91223658 |
| 118 | MP0001879_abnormal_lymphatic_vessel | 0.90718345 |
| 119 | MP0000858_altered_metastatic_potential | 0.90560814 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.90538010 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.90310782 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.90197083 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.90072077 |
| 124 | MP0002210_abnormal_sex_determination | 0.89713664 |
| 125 | MP0003279_aneurysm | 0.88775136 |
| 126 | MP0009931_abnormal_skin_appearance | 0.87933294 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.87801897 |
| 128 | MP0009278_abnormal_bone_marrow | 0.86927423 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.86066920 |
| 130 | MP0000689_abnormal_spleen_morphology | 0.85145138 |
| 131 | MP0005409_darkened_coat_color | 0.84993933 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.84770206 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.84583851 |
| 134 | MP0000653_abnormal_sex_gland | 0.83856251 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.82688584 |
| 136 | MP0003385_abnormal_body_wall | 0.80520510 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.79995786 |
| 138 | MP0005257_abnormal_intraocular_pressure | 0.79872702 |
| 139 | MP0000750_abnormal_muscle_regeneration | 0.78666809 |
| 140 | MP0000163_abnormal_cartilage_morphology | 0.78009012 |
| 141 | MP0003828_pulmonary_edema | 0.77884258 |
| 142 | MP0002429_abnormal_blood_cell | 0.77757069 |
| 143 | MP0002938_white_spotting | 0.77545239 |
| 144 | MP0003724_increased_susceptibility_to | 0.77542002 |
| 145 | MP0005670_abnormal_white_adipose | 0.76784232 |
| 146 | MP0000477_abnormal_intestine_morphology | 0.76456946 |
| 147 | MP0003959_abnormal_lean_body | 0.76387067 |
| 148 | MP0000613_abnormal_salivary_gland | 0.75999683 |
| 149 | MP0003436_decreased_susceptibility_to | 0.75253429 |
| 150 | MP0003786_premature_aging | 0.74942324 |
| 151 | MP0005620_abnormal_muscle_contractility | 0.73258837 |
| 152 | MP0002751_abnormal_autonomic_nervous | 0.72848655 |
| 153 | MP0000685_abnormal_immune_system | 0.72743412 |
| 154 | MP0006054_spinal_hemorrhage | 0.72686173 |
| 155 | MP0001145_abnormal_male_reproductive | 0.72058906 |
| 156 | MP0003755_abnormal_palate_morphology | 0.71832780 |
| 157 | MP0001191_abnormal_skin_condition | 0.71820855 |
| 158 | MP0000313_abnormal_cell_death | 0.71655982 |
| 159 | MP0003866_abnormal_defecation | 0.71552134 |
| 160 | MP0001853_heart_inflammation | 0.71130132 |
| 161 | MP0000427_abnormal_hair_cycle | 0.70220999 |
| 162 | MP0005025_abnormal_response_to | 0.69951349 |
| 163 | MP0003183_abnormal_peptide_metabolism | 0.69819237 |
| 164 | MP0003698_abnormal_male_reproductive | 0.68248915 |
| 165 | MP0004084_abnormal_cardiac_muscle | 0.67321681 |
| 166 | MP0000462_abnormal_digestive_system | 0.66936426 |
| 167 | MP0003699_abnormal_female_reproductive | 0.66919724 |
| 168 | MP0008004_abnormal_stomach_pH | 0.66010397 |
| 169 | MP0003879_abnormal_hair_cell | 0.65258753 |
| 170 | MP0009333_abnormal_splenocyte_physiolog | 0.65075499 |
| 171 | MP0002148_abnormal_hypersensitivity_rea | 0.64519668 |
| 172 | MP0001119_abnormal_female_reproductive | 0.61669584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 5.66167156 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.35582655 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.19236944 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.13445351 |
| 5 | Nemaline bodies (HP:0003798) | 4.96678202 |
| 6 | Reticulocytopenia (HP:0001896) | 4.96074592 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 4.90478007 |
| 8 | Exercise-induced myalgia (HP:0003738) | 4.88611431 |
| 9 | Distal arthrogryposis (HP:0005684) | 4.19873858 |
| 10 | Muscle stiffness (HP:0003552) | 3.92873572 |
| 11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.81590007 |
| 12 | Abnormal hemoglobin (HP:0011902) | 3.66220239 |
| 13 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.64444158 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.63678038 |
| 15 | Pallor (HP:0000980) | 3.60802480 |
| 16 | Type 2 muscle fiber atrophy (HP:0003554) | 3.54934005 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40110323 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40110323 |
| 19 | Macrocytic anemia (HP:0001972) | 3.36352111 |
| 20 | Neck muscle weakness (HP:0000467) | 3.32732022 |
| 21 | Thrombocytosis (HP:0001894) | 3.31971534 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.31837224 |
| 23 | Bilateral microphthalmos (HP:0007633) | 3.30575679 |
| 24 | Absent phalangeal crease (HP:0006109) | 3.30573215 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29185597 |
| 26 | Reduced antithrombin III activity (HP:0001976) | 3.28336844 |
| 27 | Nasolacrimal duct obstruction (HP:0000579) | 3.21183150 |
| 28 | Concave nail (HP:0001598) | 3.12185667 |
| 29 | Lip pit (HP:0100267) | 3.02101426 |
| 30 | Partial duplication of thumb phalanx (HP:0009944) | 3.01273782 |
| 31 | Rimmed vacuoles (HP:0003805) | 3.00059606 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 2.94707256 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94707256 |
| 34 | Petechiae (HP:0000967) | 2.93547224 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 2.92893408 |
| 36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.92491946 |
| 37 | Popliteal pterygium (HP:0009756) | 2.91806186 |
| 38 | Partial duplication of the phalanx of hand (HP:0009999) | 2.89681058 |
| 39 | Bulbar palsy (HP:0001283) | 2.78082177 |
| 40 | Myopathic facies (HP:0002058) | 2.74473296 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72787509 |
| 42 | Malignant hyperthermia (HP:0002047) | 2.72488589 |
| 43 | Hypotrichosis (HP:0001006) | 2.70933971 |
| 44 | Chromsome breakage (HP:0040012) | 2.70625150 |
| 45 | Sparse eyelashes (HP:0000653) | 2.70351686 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.70015516 |
| 47 | Microretrognathia (HP:0000308) | 2.66755922 |
| 48 | Multiple enchondromatosis (HP:0005701) | 2.66481476 |
| 49 | Spinal rigidity (HP:0003306) | 2.64952844 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.63180231 |
| 51 | Abnormality of placental membranes (HP:0011409) | 2.62173638 |
| 52 | Amniotic constriction ring (HP:0009775) | 2.62173638 |
| 53 | Abnormal lung lobation (HP:0002101) | 2.62015969 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 2.61088294 |
| 55 | Bundle branch block (HP:0011710) | 2.57835816 |
| 56 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.57704877 |
| 57 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.55097448 |
| 58 | Aplasia of the musculature (HP:0100854) | 2.54829610 |
| 59 | Hyporeflexia of lower limbs (HP:0002600) | 2.54758058 |
| 60 | Abnormal finger flexion creases (HP:0006143) | 2.51678313 |
| 61 | Rib fusion (HP:0000902) | 2.51211746 |
| 62 | Myoglobinuria (HP:0002913) | 2.48632082 |
| 63 | Myositis (HP:0100614) | 2.48515572 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.46690215 |
| 65 | B lymphocytopenia (HP:0010976) | 2.44702642 |
| 66 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44491467 |
| 67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39247237 |
| 68 | Rhabdomyosarcoma (HP:0002859) | 2.37345895 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.35910094 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.34778573 |
| 71 | Abnormality of the lacrimal duct (HP:0011481) | 2.33439114 |
| 72 | Methylmalonic aciduria (HP:0012120) | 2.33276142 |
| 73 | Embryonal renal neoplasm (HP:0011794) | 2.32985559 |
| 74 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.32140269 |
| 75 | Round ear (HP:0100830) | 2.30949772 |
| 76 | Posterior subcapsular cataract (HP:0007787) | 2.30733622 |
| 77 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.30326131 |
| 78 | Down-sloping shoulders (HP:0200021) | 2.28281279 |
| 79 | Granulocytopenia (HP:0001913) | 2.27008229 |
| 80 | Myelodysplasia (HP:0002863) | 2.24798885 |
| 81 | Unsteady gait (HP:0002317) | 2.22235835 |
| 82 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.20470370 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.19203909 |
| 84 | Myotonia (HP:0002486) | 2.18971774 |
| 85 | Metaphyseal dysplasia (HP:0100255) | 2.18508325 |
| 86 | Anterior segment dysgenesis (HP:0007700) | 2.17036776 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.16053115 |
| 88 | Erythema (HP:0010783) | 2.15818740 |
| 89 | Exercise-induced muscle cramps (HP:0003710) | 2.15325202 |
| 90 | Meckel diverticulum (HP:0002245) | 2.15247379 |
| 91 | Progressive muscle weakness (HP:0003323) | 2.15061188 |
| 92 | Scapular winging (HP:0003691) | 2.14929754 |
| 93 | Mesangial abnormality (HP:0001966) | 2.13785282 |
| 94 | IgM deficiency (HP:0002850) | 2.12110557 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11432792 |
| 96 | Male infertility (HP:0003251) | 2.10408818 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10323263 |
| 98 | 3-Methylglutaconic aciduria (HP:0003535) | 2.09400372 |
| 99 | Fatigable weakness (HP:0003473) | 2.08937536 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 2.08937536 |
| 101 | Colon cancer (HP:0003003) | 2.08714291 |
| 102 | Gowers sign (HP:0003391) | 2.06649373 |
| 103 | Radial bowing (HP:0002986) | 2.06515094 |
| 104 | Abnormality of the ileum (HP:0001549) | 2.05014368 |
| 105 | Increased IgE level (HP:0003212) | 2.03990389 |
| 106 | Hepatoblastoma (HP:0002884) | 2.03935741 |
| 107 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.03122420 |
| 108 | Ulnar deviation of the wrist (HP:0003049) | 2.02385459 |
| 109 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.01935794 |
| 110 | Pancytopenia (HP:0001876) | 2.01819467 |
| 111 | Abnormality of the nasolacrimal system (HP:0000614) | 2.01798750 |
| 112 | Muscle fiber atrophy (HP:0100295) | 2.01077277 |
| 113 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99765516 |
| 114 | Sensory axonal neuropathy (HP:0003390) | 1.99587521 |
| 115 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96644479 |
| 116 | Abnormality of the preputium (HP:0100587) | 1.96065918 |
| 117 | Neoplasm of striated muscle (HP:0009728) | 1.96021211 |
| 118 | Abnormality of hair growth rate (HP:0011363) | 1.95321531 |
| 119 | Slow-growing hair (HP:0002217) | 1.95321531 |
| 120 | Acute myeloid leukemia (HP:0004808) | 1.93228429 |
| 121 | Fetal akinesia sequence (HP:0001989) | 1.90602993 |
| 122 | Heart block (HP:0012722) | 1.90303173 |
| 123 | Abnormality of the salivary glands (HP:0010286) | 1.89951314 |
| 124 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89947626 |
| 125 | Abnormality of the columella (HP:0009929) | 1.88382188 |
| 126 | Woolly hair (HP:0002224) | 1.88093496 |
| 127 | Combined immunodeficiency (HP:0005387) | 1.87681234 |
| 128 | Easy fatigability (HP:0003388) | 1.87309449 |
| 129 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85483436 |
| 130 | Hypochromic anemia (HP:0001931) | 1.85342605 |
| 131 | Acute lymphatic leukemia (HP:0006721) | 1.84562370 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.84371303 |
| 133 | Abnormal atrioventricular conduction (HP:0005150) | 1.84149063 |
| 134 | Hip contracture (HP:0003273) | 1.83801092 |
| 135 | Atresia of the external auditory canal (HP:0000413) | 1.83593451 |
| 136 | Abnormality of the axillary hair (HP:0100134) | 1.82457859 |
| 137 | Abnormality of secondary sexual hair (HP:0009888) | 1.82457859 |
| 138 | Trismus (HP:0000211) | 1.81175612 |
| 139 | Facial diplegia (HP:0001349) | 1.80736965 |
| 140 | Abnormality of the anterior chamber (HP:0000593) | 1.78622422 |
| 141 | Eosinophilia (HP:0001880) | 1.78417557 |
| 142 | Hypophosphatemic rickets (HP:0004912) | 1.78152159 |
| 143 | Thin bony cortex (HP:0002753) | 1.76874471 |
| 144 | Depressed nasal ridge (HP:0000457) | 1.76830498 |
| 145 | Nonprogressive disorder (HP:0003680) | 1.76830263 |
| 146 | Chronic otitis media (HP:0000389) | 1.76567437 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.75775822 |
| 148 | Nonimmune hydrops fetalis (HP:0001790) | 1.75384477 |
| 149 | Hypochromic microcytic anemia (HP:0004840) | 1.75250917 |
| 150 | Patchy hypopigmentation of hair (HP:0011365) | 1.75192059 |
| 151 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74576493 |
| 152 | Calcaneovalgus deformity (HP:0001848) | 1.74485120 |
| 153 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74253386 |
| 154 | Short middle phalanx of the 5th finger (HP:0004220) | 1.71884030 |
| 155 | Shawl scrotum (HP:0000049) | 1.71720045 |
| 156 | Deformed tarsal bones (HP:0008119) | 1.70976152 |
| 157 | Fragile nails (HP:0001808) | 1.70937232 |
| 158 | Respiratory difficulties (HP:0002880) | 1.70900468 |
| 159 | Nasal polyposis (HP:0100582) | 1.68390269 |
| 160 | Triphalangeal thumb (HP:0001199) | 1.67693058 |
| 161 | Anomalous pulmonary venous return (HP:0010772) | 1.66185412 |
| 162 | Conical tooth (HP:0000698) | 1.64120978 |
| 163 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.62928983 |
| 164 | Abnormality of the nasal mucosa (HP:0000433) | 1.61904392 |
| 165 | Duplication of thumb phalanx (HP:0009942) | 1.61873492 |
| 166 | Premature ovarian failure (HP:0008209) | 1.61206565 |
| 167 | Abnormality of the parietal bone (HP:0002696) | 1.61119047 |
| 168 | Weak cry (HP:0001612) | 1.61107282 |
| 169 | White forelock (HP:0002211) | 1.60684004 |
| 170 | Episodic fever (HP:0001954) | 1.59921993 |
| 171 | Renal Fanconi syndrome (HP:0001994) | 1.59182558 |
| 172 | Asplenia (HP:0001746) | 1.58847174 |
| 173 | Short 5th finger (HP:0009237) | 1.57598070 |
| 174 | Abnormality of T cell physiology (HP:0011840) | 1.57413119 |
| 175 | Testicular atrophy (HP:0000029) | 1.57400123 |
| 176 | Flared metaphyses (HP:0003015) | 1.57229290 |
| 177 | Preauricular skin tag (HP:0000384) | 1.56804618 |
| 178 | Pili torti (HP:0003777) | 1.56444812 |
| 179 | Pendular nystagmus (HP:0012043) | 1.56301393 |
| 180 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.55846883 |
| 181 | Abnormal protein glycosylation (HP:0012346) | 1.55846883 |
| 182 | Abnormal glycosylation (HP:0012345) | 1.55846883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.96276507 |
| 2 | OBSCN | 3.31536269 |
| 3 | VRK2 | 3.11848088 |
| 4 | ARAF | 2.97374957 |
| 5 | MAP3K13 | 2.92958416 |
| 6 | GRK5 | 2.91124132 |
| 7 | CDK12 | 2.86602910 |
| 8 | PIM2 | 2.76995705 |
| 9 | KIT | 2.72529438 |
| 10 | ERN1 | 2.68704562 |
| 11 | EEF2K | 2.61155486 |
| 12 | KDR | 2.59930111 |
| 13 | CSF1R | 2.56942290 |
| 14 | PINK1 | 2.51031666 |
| 15 | TGFBR2 | 2.42294451 |
| 16 | NME2 | 2.32167829 |
| 17 | MATK | 2.29946867 |
| 18 | MAPKAPK3 | 2.25261689 |
| 19 | MAP2K3 | 2.21899988 |
| 20 | ADRBK2 | 2.20938365 |
| 21 | TAOK3 | 2.20855156 |
| 22 | TLK1 | 2.10894885 |
| 23 | GRK6 | 2.09004356 |
| 24 | STK10 | 2.04727479 |
| 25 | FLT3 | 1.95321038 |
| 26 | MOS | 1.94948907 |
| 27 | RPS6KB2 | 1.92850042 |
| 28 | TEC | 1.91623334 |
| 29 | CDK7 | 1.76392202 |
| 30 | CDK8 | 1.75650646 |
| 31 | BTK | 1.70161618 |
| 32 | BRD4 | 1.70019592 |
| 33 | TGFBR1 | 1.68023132 |
| 34 | GRK1 | 1.68023103 |
| 35 | BRSK2 | 1.65321471 |
| 36 | MUSK | 1.57282418 |
| 37 | MAPKAPK5 | 1.56631957 |
| 38 | NUAK1 | 1.53948044 |
| 39 | MAP3K6 | 1.48617570 |
| 40 | PHKG2 | 1.40532510 |
| 41 | PHKG1 | 1.40532510 |
| 42 | MAP2K6 | 1.38853564 |
| 43 | PRKG2 | 1.38083847 |
| 44 | CDK19 | 1.34242866 |
| 45 | WEE1 | 1.33713759 |
| 46 | GRK7 | 1.28652435 |
| 47 | TRPM7 | 1.27094555 |
| 48 | CLK1 | 1.26864938 |
| 49 | SCYL2 | 1.26006208 |
| 50 | MKNK1 | 1.25126166 |
| 51 | LRRK2 | 1.25003264 |
| 52 | DYRK3 | 1.21976373 |
| 53 | MARK3 | 1.21664043 |
| 54 | PIK3CG | 1.19333341 |
| 55 | HIPK2 | 1.16567164 |
| 56 | SRPK1 | 1.16381905 |
| 57 | MAP3K3 | 1.13911809 |
| 58 | TBK1 | 1.09831658 |
| 59 | TAOK1 | 1.05162871 |
| 60 | TTK | 1.05136051 |
| 61 | WNK1 | 1.04301667 |
| 62 | PBK | 1.01183216 |
| 63 | TNK2 | 0.96555188 |
| 64 | CSNK1G1 | 0.96337485 |
| 65 | STK16 | 0.94740756 |
| 66 | MAP4K1 | 0.94017168 |
| 67 | TXK | 0.91805537 |
| 68 | CDK3 | 0.87414000 |
| 69 | CDK9 | 0.86229720 |
| 70 | CSNK1G3 | 0.85242700 |
| 71 | MAPK11 | 0.85220294 |
| 72 | ILK | 0.84518987 |
| 73 | EIF2AK2 | 0.84412935 |
| 74 | MAP3K14 | 0.84053538 |
| 75 | MAP4K2 | 0.83797195 |
| 76 | MAP3K7 | 0.83052898 |
| 77 | ADRBK1 | 0.82095891 |
| 78 | PLK1 | 0.80397299 |
| 79 | MAPK12 | 0.80229886 |
| 80 | AURKB | 0.79597415 |
| 81 | CAMK4 | 0.78486796 |
| 82 | PAK4 | 0.77842206 |
| 83 | CSNK1A1L | 0.76732118 |
| 84 | VRK1 | 0.76401333 |
| 85 | MAP3K1 | 0.76165689 |
| 86 | CHEK2 | 0.75786467 |
| 87 | IKBKB | 0.75676243 |
| 88 | TAOK2 | 0.70692126 |
| 89 | MAP3K12 | 0.70451389 |
| 90 | BRAF | 0.70269767 |
| 91 | MAPK4 | 0.70101298 |
| 92 | MKNK2 | 0.69476997 |
| 93 | EPHB2 | 0.69037377 |
| 94 | CDK4 | 0.66932740 |
| 95 | TNIK | 0.63953693 |
| 96 | ZAP70 | 0.63921239 |
| 97 | JAK3 | 0.63325207 |
| 98 | TIE1 | 0.63185616 |
| 99 | NLK | 0.62145186 |
| 100 | MAP3K11 | 0.60842820 |
| 101 | PIM1 | 0.59914553 |
| 102 | ITK | 0.58786402 |
| 103 | MST4 | 0.58148457 |
| 104 | BLK | 0.57803276 |
| 105 | NEK6 | 0.57499850 |
| 106 | CDC7 | 0.57269302 |
| 107 | PRKD2 | 0.57253168 |
| 108 | PAK2 | 0.55495432 |
| 109 | MAPK7 | 0.55096178 |
| 110 | PRKCQ | 0.54824148 |
| 111 | LIMK1 | 0.53663396 |
| 112 | OXSR1 | 0.53258398 |
| 113 | RPS6KA5 | 0.53200769 |
| 114 | AURKA | 0.51859428 |
| 115 | LATS1 | 0.51458583 |
| 116 | MST1R | 0.51328903 |
| 117 | TTN | 0.51190156 |
| 118 | NME1 | 0.51031992 |
| 119 | LATS2 | 0.49375420 |
| 120 | BUB1 | 0.47260283 |
| 121 | FES | 0.47257761 |
| 122 | SYK | 0.46514501 |
| 123 | BRSK1 | 0.45359517 |
| 124 | TESK2 | 0.43941362 |
| 125 | NEK2 | 0.43817334 |
| 126 | MAPKAPK2 | 0.43312152 |
| 127 | MARK2 | 0.43153175 |
| 128 | RPS6KL1 | 0.43103334 |
| 129 | RPS6KC1 | 0.43103334 |
| 130 | RPS6KA6 | 0.42779738 |
| 131 | PAK1 | 0.42585145 |
| 132 | TESK1 | 0.41602468 |
| 133 | RPS6KA4 | 0.40225612 |
| 134 | DAPK1 | 0.38316018 |
| 135 | ZAK | 0.37992236 |
| 136 | ATR | 0.37426953 |
| 137 | NEK9 | 0.36661705 |
| 138 | RAF1 | 0.36234222 |
| 139 | CAMK2G | 0.35746734 |
| 140 | AKT2 | 0.35498089 |
| 141 | MAP2K4 | 0.35275371 |
| 142 | MYLK | 0.34448488 |
| 143 | CCNB1 | 0.34325665 |
| 144 | EIF2AK3 | 0.32996585 |
| 145 | EPHB1 | 0.30968181 |
| 146 | ABL2 | 0.30640876 |
| 147 | MAP2K2 | 0.29785767 |
| 148 | MAPK15 | 0.28518107 |
| 149 | LCK | 0.27923854 |
| 150 | CSNK1G2 | 0.27911521 |
| 151 | MAP3K8 | 0.27748875 |
| 152 | MAP3K5 | 0.27526000 |
| 153 | CDK2 | 0.26750615 |
| 154 | EPHA3 | 0.26315133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.35434055 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.52407633 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.19285416 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.43573652 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.42024328 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.38988065 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34044215 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.25809827 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11265336 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.96574563 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 1.96375054 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.96343280 |
| 13 | Thyroid cancer_Homo sapiens_hsa05216 | 1.92743794 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86988675 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.80666235 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.74977518 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73718591 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.69956768 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.67683429 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66242143 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.66128708 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66074771 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63247923 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.58047567 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.51415632 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50267761 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.48473947 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.46765687 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45650850 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43046378 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42137229 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.33360997 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32521604 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30124688 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.29581875 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22338428 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20277330 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19896415 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19308545 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06682939 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06223563 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04551292 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03832144 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03752146 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00170168 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98313857 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98130233 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97768149 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97516662 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96974990 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96410122 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95391088 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95237258 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95204079 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.92380768 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92025018 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90330609 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89872463 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88932145 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87455854 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86417036 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84302429 |
| 63 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.83878176 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82602232 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82310843 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81772279 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80950206 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.79822709 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79596921 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77555867 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74570054 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.73107345 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72215178 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70497569 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70061017 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69822170 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69655646 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.69056993 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67108831 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66953927 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66366127 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66277669 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65201285 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.64387282 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63551150 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63477614 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.61722954 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60205549 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57821170 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57805462 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57115289 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56852269 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56658865 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55536843 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53887614 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53460614 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53420449 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53215381 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52705712 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52106287 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52055266 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51561883 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50638832 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.50369558 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49910972 |
| 106 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49736287 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49577848 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49171622 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49048155 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46886553 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45864506 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45452680 |
| 113 | Protein export_Homo sapiens_hsa03060 | 0.44607062 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44451181 |
| 115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43775222 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43544274 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42842098 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42438731 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.42143202 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41216172 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41031838 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40392749 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39562813 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38108214 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38098358 |
| 126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37996685 |
| 127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37982161 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | 0.37970661 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37803736 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36656122 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36404128 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36041686 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35086057 |
| 134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34766228 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34559166 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34431333 |
| 137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33613848 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32751785 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32713453 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32127506 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.31850509 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31525919 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31192161 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29719492 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29570804 |
| 146 | Measles_Homo sapiens_hsa05162 | 0.29370818 |
| 147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29155844 |
| 148 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29070720 |
| 149 | Influenza A_Homo sapiens_hsa05164 | 0.28244873 |
| 150 | Malaria_Homo sapiens_hsa05144 | 0.27817325 |

